SCHEMBL8712537

SCHEMBL8712537

CCCCCN(CC(F)(F)F)C(=O)C1c2ccccc2-c2cccc(N3CCC(NC(=O)c4ccccc4Oc4ccccc4)CC3)c21

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CCR3 P51677 3/20 0.43
▸ HTR7 P34969 4/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ DRD2 P14416 1/20 0.39
▸ HTR6 P50406 1/20 0.39
▸ MAPT P10636 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ SLC6A12 P48065 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ KDM5A P29375 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ CNR1 P21554 1/20 0.35
▸ CNR2 P34972 1/20 0.35
▸ HPGDS O60760 1/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8717983 0.98 CCR3 (0.43) CCR3HTR7HTR1ADRD2HTR6
SCHEMBL8665525 0.96 CCR3 (0.40) CCR3HTR7HTR1ADRD2HTR6
SCHEMBL8665515 0.94 CCR3 (0.41) CCR3HTR7HTR1ADRD2HTR6
SCHEMBL8524381 0.90 CCR3 (0.42) CCR3HTR7HTR1ADRD2HTR6
SCHEMBL8484454 0.89 NPSR1 (0.42) CCR3DRD2SLC6A12MEN1KMT2A
SCHEMBL8653114 0.88 CCR3 (0.42) CCR3HTR7HTR1ADRD2HTR6
SCHEMBL8485533 0.87 NPSR1 (0.42) CCR3DRD2SLC6A12MEN1KMT2A
SCHEMBL8666998 0.85 CCR3 (0.40) CCR3HTR7HTR1ADRD2HTR6
SCHEMBL8713180 0.85 CKS1B (0.41) DRD2CNR1CNR2
SCHEMBL8668018 0.85 MAPT (0.39) CCR3HTR7HTR1ADRD2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5739135-A PREVENTING OR TREATING ATHEROSCLEROSIS, PANCREATITIS SECONDARY TO HYPERTRIGLYCERIDEMIA, HYPERGLYCEMIA, OBESITY BRISTOL-MYERS SQUIBB COMPANY (US) 1998-04-14 — — US disclosed
Send feedback